Navepegritide NDA submitted to treat children with achondroplasia
Jay Rubinstein, MD, PhD: Why children should receive genetic testing for hearing loss
Weekly review: Multiple FDA approvals, expert discussions and more
FDA approves fitusiran for hemophilia A, B patients aged 12 years and up